72 related articles for article (PubMed ID: 1286181)
1. Therapeutic effect of andriol on serum lipids and apolipoproteins in elderly male coronary heart disease patients.
Wu S; Weng X
Chin Med Sci J; 1992 Sep; 7(3):137-41. PubMed ID: 1286181
[TBL] [Abstract][Full Text] [Related]
2. [Antianginal and lipid lowering effects of oral androgenic preparation (Andriol) on elderly male patients with coronary heart disease].
Wu SZ; Weng XZ; Yao XX
Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):235-8. PubMed ID: 8156848
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients.
Wu SZ; Weng XZ
Chin Med J (Engl); 1993 Jun; 106(6):415-8. PubMed ID: 8222891
[TBL] [Abstract][Full Text] [Related]
4. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
Artery; 1983; 12(1):1-23. PubMed ID: 6431945
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of testosterone undecanoate on the lipoprotein profiles in healthy elderly men. A placebo controlled study.
Uyanik BS; Ari Z; Gümüs B; Yiğitoğlu MR; Arslan T
Jpn Heart J; 1997 Jan; 38(1):73-82. PubMed ID: 9186283
[TBL] [Abstract][Full Text] [Related]
6. Sex hormones, lipids, lipoprotein cholesterols, and apolipoproteins in normal and obese subjects: atherogenic relationships.
Mendoza SG; Zerpa A; Velazquez E; Schwarzenberg A; Hynd B; Kashyap ML; Laskarzewski P; Glueck CJ
Int J Obes; 1986; 10(6):427-41. PubMed ID: 3100468
[TBL] [Abstract][Full Text] [Related]
7. [Plasma levels of lipids, lipoproteins and apolipoproteins affected by endogenous testosterone].
Zhao S; Li X; Wang Z
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(3):299-301. PubMed ID: 10681765
[TBL] [Abstract][Full Text] [Related]
8. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease].
Liu BW; Shao MZ; Yuan HJ; Wu ZF; Zhang ZH; Fu MD; Zhang RJ; Fan P
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of apolipoprotein B and AI determinations in coronary heart disease].
Li JZ; Wang JJ; Niu QT
Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):351-5, 381-2. PubMed ID: 2510981
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and experimental study on its regulatory function of yi xin decoction (heart-nourishing decoction) to lipids metabolic disturbance in coronary heart disease].
Liang H; Wang X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Jul; 12(7):406-8, 388. PubMed ID: 1392490
[TBL] [Abstract][Full Text] [Related]
11. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.
Singh AB; Hsia S; Alaupovic P; Sinha-Hikim I; Woodhouse L; Buchanan TA; Shen R; Bross R; Berman N; Bhasin S
J Clin Endocrinol Metab; 2002 Jan; 87(1):136-43. PubMed ID: 11788637
[TBL] [Abstract][Full Text] [Related]
12. [Changes in serum sex hormone levels and their relation to blood lipids in male patients with coronary disease].
Yang XC; Weng XZ
Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):329-31. PubMed ID: 2509005
[No Abstract] [Full Text] [Related]
13. Imbalance of testosterone/estradiol promotes male CHD development.
Zheng HY; Li Y; Dai W; Wei CD; Sun KS; Tong YQ
Biomed Mater Eng; 2012; 22(1-3):179-85. PubMed ID: 22766718
[TBL] [Abstract][Full Text] [Related]
14. [Effects of sex hormones on plasma lipoproteins in middle older age non-diabetes, diabetes and coronary heart disease].
Yang WY; Cao HB; Pan XR
Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):552-5. PubMed ID: 8269788
[TBL] [Abstract][Full Text] [Related]
15. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
16. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
[TBL] [Abstract][Full Text] [Related]
17. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
18. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
Falkeborn M; Lithell H; Persson I; Vessby B; Naessén T
Climacteric; 2002 Sep; 5(3):240-8. PubMed ID: 12419082
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
[TBL] [Abstract][Full Text] [Related]
20. [Comparative characteristics of the basic blood lipid and apolipoprotein spectrum in groups of patients from Moscow and Bordeaux with ischemic heart disease].
Perova NV; Bonne Zh; Nechaev AS; Shcherbakova IA; Metel'skaia VA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(1):66-72. PubMed ID: 3707722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
